DOCSLIB.ORG

The Transcript of a Witness Seminar Held by the Wellcome Trust Centre for the History of Medicine at UCL, London, on 9 May 2006 Edited by L a Reynolds and E M Tansey

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
The Transcript of a Witness Seminar Held by the Wellcome Trust Centre for the History of Medicine at UCL, London, on 9 May 2006 Edited by L a Reynolds and E M Tansey MEDICAL ETHICS EDUCATION IN BRITAIN, 1963–1993 The transcript of a Witness Seminar held by the Wellcome Trust Centre for the History of Medicine at UCL, London, on 9 May 2006 Edited by L A Reynolds and E M Tansey Volume 31 2007 ©The Trustee of the Wellcome Trust, London, 2007 First published by the Wellcome Trust Centre for the History of Medicine at UCL, 2007 The Wellcome Trust Centre for the History of Medicine at UCL is funded by the Wellcome Trust, which is a registered charity, no. 210183. ISBN 978 985484 113 4 All volumes are freely available online following the links to Publications/Wellcome Witnesses at www.ucl.ac.uk/histmed Technology Transfer in Britain:The case of monoclonal antibodies; Self and Non-Self: A history of autoimmunity; Endogenous Opiates; The Committee on Safety of Drugs • Making the Human Body Transparent: The impact of NMR and MRI; Research in General Practice; Drugs in Psychiatric Practice; The MRC Common Cold Unit • Early Heart Transplant Surgery in the UK • Haemophilia: Recent history of clinical management • Looking at the Unborn: Historical aspects of obstetric ultrasound • Post Penicillin Antibiotics: From acceptance to resistance? • Clinical Research in Britain, 1950–1980 • Intestinal Absorption • Origins of Neonatal Intensive Care in the UK • British Contributions to Medical Research and Education in Africa after the Second World War • Childhood Asthma and Beyond • Maternal Care • Population-based Research in South Wales:The MRC Pneumoconiosis Research Unit and the MRC Epidemiology Unit • Peptic Ulcer: Rise and fall • Leukaemia • The MRC Applied Psychology Unit • Genetic Testing • Foot and Mouth Disease: The 1967 outbreak and its aftermath • EnvironmentalToxicology: The legacy of Silent Spring • Cystic Fibrosis • Innovation in Pain Management • The Rhesus Factor and Disease Prevention • The Recent History of Platelets in Thrombosis and Other Disorders • Short-course Chemotherapy for Tuberculosis • Prenatal Corticosteroids for Reducing Morbidity and Mortality after Preterm Birth • Public Health in the 1980s and 1990s: Decline and rise? • Cholesterol, Atherosclerosis and Coronary Disease in the UK, 1950–2000 • Development of Physics Applied to Medicine in the UK, 1945–1990 • Early Development of Total Hip Replacement • The Discovery, Use and Impact of Platinum Salts as Chemotherapy Agents for Cancer • Medical Ethics Education in Britain, 1963–1993 CONTENTS Illustrations and credits v Witness Seminars: Meetings and publications; Acknowledgements E M Tansey and L A Reynolds vii Introduction Sir Kenneth Calman xxi Transcript Edited by L A Reynolds and E M Tansey 1 Appendix 1 A retrospective study and personal reflection on the influence of the Medical Groups by Ted Shotter, 16 September 2006 71 Appendix 2 Some reflections on the London Medical Group 118 Appendix 3 LMG lecture list, 1981/2 122 Appendix 4 Topics of Lectures, Symposia and Study Seminars: Associated Medical Groups, 1981/2 127 Appendix 5 Attendance at LMG lectures, symposia and annual conferences, 1972/3–81/2 131 Appendix 6 Questionnaire 132 Appendix 7 London Medical Group Presidents, 1963–89 136 Appendix 8 Donations to the LMG and the Institute of Medical Ethics, 1967–88 137 Appendix 9 Attendance at 104 lectures and symposia by topics, 1971/2 141 References 143 Biographical notes 169 Glossary 193 Index 203 ILLUSTRATIONS AND CREDITS Figure 1 Lord Amulree, Chairman of the Governing Body of the London Medical Group from 1968–81. Reproduced by permission of the Very Revd Edward Shotter. 9 Figure 2 Lord Amulree and Dr [now Professor] Alastair Campbell at the launch of the Journal of Medical Ethics in 1975. Reproduced by permission of the Very Revd Edward Shotter. 11 Figure 3 Sir Douglas Ranger, Dean of the Middlesex Hospital Medical School, at the 18th Annual Conference, ‘The Creative Urge’, held at the Royal College of Surgeons, February 1981. Reproduced by permission of the Very Revd Edward Shotter. 14 Figure 4 The Revd Professor G R Dunstan, the Revd Dr Mary Seller and Professor Norman Morris at the 18th Annual Conference on ‘The Creative Urge’, held at the Royal College of Surgeons, February 1981. Reproduced by permission of the Very Revd Edward Shotter. 17 Figure 5 Tim Helme, LMG President 1975/6 and Convenor, leading Dr Colin Murray Parkes to open the 13th Annual Conference, ‘Death: The conspiracy of silence’, held at the Middlesex Hospital Medical School, February 1976. Reproduced by permission of the Very Revd Edward Shotter. 20 Figure 6 Dr Tom Oppé (1925–2007), Dr Cicely Saunders (1918–2004) and Prebendary Edward Shotter at the 15th Annual Conference on ‘Pain: A Necessity?’, held at the Charing Cross Hospital Medical School, February 1978. Reproduced by permission of the Very Revd Edward Shotter. 20 v Figure 7 Professor John Marshall speaking to the President of the LMG, Patrick Magee (Westminster), at the pre- conference dinner and briefing of speakers for the 18th Annual Conference, ‘The Creative Urge’, held at the Royal College of Surgeons, London, February 1981. Reproduced by permission of the Very Revd Edward Shotter. 22 Figure 8 Cover of the 1993 edition of Tomorrow’s Doctors. Reproduced by permission of the General Medical Council. 39 Figure 9 One example of the evolving Seedhouse ethical grid. Reproduced by permission of Professor David Seedhouse. 54 Figure 10 The Pond Report, 1987. Reproduced by permission of Professor Kenneth Boyd. 57 Figure 11 Professor Archie Duncan and Professor Dick Welbourn, Chairman of the Editorial Board, at the launch of the Journal of Medical Ethics, 1975. Reproduced by permission of the Very Revd Edward Shotter. 66 Figure 12 Number of articles listed under the heading ‘Medical Ethics’ in Index Medicus, 1950–70. Reproduced by permission of the Very Revd Edward Shotter. 68 Table 1 LMG Conferences, 1965–89. 78 Attendance at the LMG conference, ‘Human Table 2 Sexuality’, held at the Royal College of Surgeons on 11–12 February, 1977. 83 vi WITNESS SEMINARS: MEETINGS AND PUBLICATIONS 1 In 1990 the Wellcome Trust created a History of Twentieth Century Medicine Group, associated with the Academic Unit of the Wellcome Institute for the History of Medicine, to bring together clinicians, scientists, historians and others interested in contemporary medical history. Among a number of other initiatives the format of Witness Seminars, used by the Institute of Contemporary British History to address issues of recent political history, was adopted, to promote interaction between these different groups, to emphasize the potential benefits of working jointly, and to encourage the creation and deposit of archival sources for present and future use. In June 1999 the Governors of the Wellcome Trust decided that it would be appropriate for the Academic Unit to enjoy a more formal academic affiliation and turned the Unit into the Wellcome Trust Centre for the History of Medicine at UCL from 1 October 2000. The Wellcome Trust continues to fund the Witness Seminar programme via its support for the Centre. The Witness Seminar is a particularly specialized form of oral history, where several people associated with a particular set of circumstances or events are invited to come together to discuss, debate, and agree or disagree about their memories. To date, the History of Twentieth Century Medicine Group has held nearly 50 such meetings, most of which have been published, as listed on pages xi–xviii. Subjects are usually proposed by, or through, members of the Programme Committee of the Group, which includes professional historians of medicine, practicing scientists and clinicians, and once an appropriate topic has been agreed, suitable participants are identified and invited. This inevitably leads to further contacts, and more suggestions of people to invite. As the organization of the meeting progresses, a flexible outline plan for the meeting is devised, usually with assistance from the meeting’s chairman, and some participants are invited to ‘set the ball rolling’ on particular themes, by speaking for a short period to initiate and stimulate further discussion. 1 The following text also appears in the ‘Introduction’ to recent volumes of Wellcome Witnesses to Twentieth Century Medicine published by the Wellcome Trust and the Wellcome Trust Centre for the History of Medicine at UCL. vii Each meeting is fully recorded, the tapes are transcribed and the unedited transcript is immediately sent to every participant. Each is asked to check his or her own contributions and to provide brief biographical details. The editors turn the transcript into readable text, and participants’ minor corrections and comments are incorporated into that text, while biographical and bibliographical details are added as footnotes, as are more substantial comments and additional material provided by participants. The final scripts are then sent to every contributor, accompanied by forms assigning copyright to the Wellcome Trust. Copies of all additional correspondence received during the editorial process are deposited with the records of each meeting in Archives and Manuscripts, Wellcome Library, London. As with all our meetings, we hope that even if the precise details of some of the technical sections are not clear to the non-specialist, the sense and significance of the events will be understandable. Our aim is for the volumes that emerge from these meetings to inform those with a general interest in the history of modern medicine and medical science; to provide historians with new insights, fresh material for study, and further themes
Load more

Recommended publications
  • Naturvidenskabernes Kanonisering. Forskere, Erkendelser Eller Kulturarv
    NORDISK MUSEOLOGI 2006 G 2, S. 27-44 Naturvidenskabernes kanonisering. Forskere, erkendelser eller kulturarv KRISTIAN HVIDTFELT NIELSEN* Title: The ”canonisation” of the natural sciences. Abstract: This paper concerns recent official attempts to place science in Denmark within the context of a cultural canon. Based on differentiation between Mode 1 and 2 knowledge production, the paper points out that such attempts are highly contextualised and contingent on their different modes of application. Consequent- ly, they entangle scientific expertise with other social skills and qualifications. Like science museums and science centres, they are a means of dealing with science in the public agora, i.e. the public sphere in which negotiations, mediations, consulta- tions and contestations regarding science increasingly take place. Analysing the am- biguities and uncertainties associated with the recent official placing of science wit- hin an overall cultural canon for Denmark, this paper concludes that even though the agora embodies antagonistic forms of interaction, it might also lead the way to producing socially robust knowledge about science. Keywords: Cultural canon, science, Mode 1 and 2 knowledge production, Mode 2 society, agora, science museums, science centres. Naturvidenskab er ikke med i den officielle, denskabskanoner samt deres bredere betyd- danske kulturkanon, som blev sat i værk af ning for offentlighedens forståelse af naturvi- Kulturministeriet i 2005 (Kulturministeriet denskab, som jeg i denne artikel vil komme 2006). Det
    [Show full text]
  • Tierversuche in Der Forschung Senatskommission Für Tierexperimentelle Forschung Der Deutschen Forschungsgemeinschaft Tierversuche in Der Forschung 3  2
    Senatskommission für tierexperimentelle Forschung der Deutschen Forschungsgemeinschaft Tierversuche in der Forschung Senatskommission für tierexperimentelle Forschung der Deutschen Forschungsgemeinschaft Tierversuche in der Forschung 2 3 Inhalt Vorwort �� � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � 4 Tierversuche und Tierschutz: Ethische Abwägungen Einführung �� � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � 6 Die Entwicklung des Tierschutzgedankens in Deutschland �� � � � � � � � � � � � � 39 Ethische Aspekte von Tierversuchen und das Solidaritätsprinzip� � � � � � � � 40 Tierversuche: Definition und Zahlen Die Übertragbarkeit aus ethisch-rechtlicher Sicht� � � � � � � � � � � � � � � � � � � � � � 45 Was ist ein Tierversuch? �� � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � 9 Das 3 R-Prinzip �� � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � 48 Wie viele Tiere werden verwendet? �� � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � 9 Alternativen zum Tierversuch� � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � 51 Wofür werden Tiere in der Forschung benötigt? �� � � � � � � � � � � � � � � � � � � � � � 11 Grenzen von Alternativmethoden� � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � 54 Welche Tierarten werden eingesetzt? ��
    [Show full text]
  • Tierversuche in Der Forschung Senatskommission Für Tierexperimentelle Forschung Der Deutschen Forschungsgemeinschaft Tierversuche in Der Forschung 2 3
    Senatskommission für tierexperimentelle Forschung der Deutschen Forschungsgemeinschaft Tierversuche in der Forschung Senatskommission für tierexperimentelle Forschung der Deutschen Forschungsgemeinschaft Tierversuche in der Forschung 2 3 Inhalt Vorwort . 4 Tierversuche und Tierschutz: Ethische Abwägungen Einführung . 6 Die Entwicklung des Tierschutzgedankens in Deutschland . 39 Ethische Aspekte von Tierversuchen und das Solidaritätsprinzip. 40 Tierversuche: Definition und Zahlen Die Übertragbarkeit aus ethisch-rechtlicher Sicht. 45 Was ist ein Tierversuch? . 9 Das 3 R-Prinzip . 48 Wie viele Tiere werden verwendet? . 9 Alternativen zum Tierversuch. 51 Wofür werden Tiere in der Forschung benötigt? . 11 Grenzen von Alternativmethoden. 54 Welche Tierarten werden eingesetzt? . 11 Die Basler Deklaration . 56 Europaweite Entwicklung . 14 Tierversuche in Deutschland: Vom Antrag bis zur Durchführung Tierexperimentelle Praxis: Einsatzbereiche für Versuchstiere Europäische Regelungen für Tierversuche . 59 Grundlagenforschung. 17 Tierversuche unter Genehmigungsvorbehalt . 60 Medizinische Forschung. 18 Rechtliche Grundlagen . 60 Nobelpreiswürdig: Herausragende wissenschaftliche Erkenntnisse . 20 Genehmigungsverfahren . 63 Diagnostik . 22 Durchführung von Tierversuchen . 64 Transplantationsmedizin . 25 Qualifizierte Überwachung. 68 Zell- und Gewebeersatz beim Menschen. 26 Belastungen für die Tiere . 69 Stammzellforschung . 27 Die Tierschutz-Verbandsklage . 71 Genomforschung . 28 Neurowissenschaften . 31 Anhang Veterinärmedizinische Forschung . 33 Tierversuche
    [Show full text]
  • The Fascinating Germ Theories on Cancer Pathogenesis G
    JBUON 2014; 19(1): 319-323 ISSN: 1107-0625, online ISSN: 2241-6293 • www.jbuon.com E-mail: [email protected] HISTORY OF ONCOLOGY The fascinating germ theories on cancer pathogenesis G. Tsoucalas1, K. Laios1, M. Karamanou1, V. Gennimata2, G. Androutsos1 1Department of History of Medicine, Medical School, University of Athens, Athens; 2Department of Microbiology, Medical School, University of Athens, Athens, Greece Summary bel Prize in 1926 that was attributed to the Danish scientist Johannes Fibiger for his work on the nematode Spiroptera as a For more than 100 years, the germ theory of cancer, pro- causative agent in cancer. Even if those theories were the result posing that microorganisms were at the origin of the disease, of fantasy and misinterpretation, they paved the way for the dominated medicine. Several eminent scientists like Etienne scientific research in oncology. Burnet, Mikhail Stepanovich Voronin, Charles-Louis Mal- assez, and Francis-Peyton Rous argued on the pathogenesis presenting their theories that implicated cocci, fungi and par- Key words: carcinogenesis, germ theories, Johannes Fibiger, asites. The impact of these theories was culminated by the No- parasitic theory Introduction transmission was explained. It is long discussed for cancer that heredity is a legend that will vanish Apart from the exogenous, strange for today’s when contagion will be proved” [1]. medical world, misconceptions about cancer (can- cer villages, cancer houses, cancer countries, can- The germs of cancer: coccus and fungi cer races), the microbial theory of cancer held a significant place in the scientific community dur- Several scientists believed that cancerous ing the second half of the 19th century, similarly to germ had a preference for wetlands and could be tuberculosis during the previous decades.
    [Show full text]
  • EDITORIAL Year's Comments for 2005
    EDITORIAL INTERNATIONAL MICROBIOLOGY (2005) 8:231-234 Year’s comments for 2005 Ricardo Guerrero Editor-in-Chief, INT. MICROBIOL. E-mail: [email protected] For several years, new sequences of microbial genomes have dogma. Conclusive evidence for a pathogenic role of H. pylori been the highlights of microbiology and a major topic of our came from trials showing that elimination of the bacterium dra- yearly comments. But sequencing has become “routine” and, at matically changed the clinical course of ulcer. This finding was the time this editorial is being written, the complete sequences confirmed by Marshall, who swallowed a broth of H. pylori and of 284 prokaryotic genomes and 40 eukaryotic genomes have soon thereafter developed gastritis, the prelude to ulcers. He been published. This allows us to focus our comments on those recovered from the disease after treatment with antibiotics. events from 2005 that have attracted the attention of both (Warren could not join him in the experiment because he already researchers and the media. These include the Nobel Prize in suffered from peptic ulcer.) Subsequently, the two investigators Physiology or Medicine, which was awarded for the discovery successfully treated other people suffering from ulcers, in the of the role of Helicobacter pylori as the causal agent of gastric process clearly identifying the bacterium as the culprit. In 1994, ulcers; the worldwide effort to fight malaria, a disease that main- H. pylori was the first bacterium, and the second infectious ly affects developing countries; and the global spread of avian organism after hepatitis B virus, to be classified as a class I car- influenza, which is becoming a panzootic.
    [Show full text]
  • Endnu En Nobelpris Baseret På Dyreforsøg – Denne Gang for Opdagelsen Af Hepatitis C-Virus
    Forsøgsdyr Endnu en Nobelpris baseret på dyreforsøg – denne gang for opdagelsen af hepatitis c-virus TEKST AAGE KRISTIAN OLSEN ALSTRUP / SPECIALDYRLÆGE, PH.D. & FREELANCEJOURNALIST en 5. oktober 2020 transmit- den, for Nobelkomiteen offentliggør terede Nobelkomiteen live ikke deres interne overvejelser før fra Stockholm, at årets No- mange år efter uddelingerne. Også danskere har modtaget Nobelpriser Dbelpris i fysiologi eller medicin går til for dyreforsøg de tre videnskabsmænd, der opdage- En ukendt dræber var på spil de hepatitis c-virus hos mennesker. Det var tilbage i 1970’erne og I alt er Nobelprisen i fysiologi eller En sygdom, der fører til kronisk he- 1980’erne, at de tre forskere gjorde de- medicin givet til fem danskere. Fire patitis og undertiden levercancer, og res epokegørende indsats i hepati- af dem har fået prisen på baggrund som stadig koster op mod en halv tis-forskningen. Smitsom leverbe- af dyreforsøg og en enkelt på bag- million mennesker livet hvert år. tændelse var en frygtet sygdom, og grund af menneskeforsøg. Den før- Tidligere samme morgenen var de man kendte til eksistensen af to virus, ste var Niels Ryberg Finsen (1860- 1904), der i 1903 modtog tre forskere blevet ringet op af Nobel- nemlig hepatitis a og hepatitis b. Nobelprisen for sin behandling af komiteen for at få den gode nyhed – Imidlertid opdagede den første af hudtuberkolose med lysterapi. Han så tidligt, at komiteen måtte ringe prisvinderne, Harvey Alter i 1975, at udførte ikke dyreforsøg, formentlig dem op flere gange, før der var forbin- en stor del af hepatitis-patienterne, fordi forskningen foregik så tidligt, delse.
    [Show full text]
  • Johannes Fibiger
    J OHANNES F I B I G E R Investigations on Spiroptera carcinoma and the experimental induction of cancer Nobel Lecture, December 12, 1927 Ladies and Gentlemen. Now that it is my honour to address the Swedish Society of Medicine, I should like to begin by expressing the debt of gratitude I owe to this Society. In 1913, some six months after I had published my first work on Spiroptera carcinoma, the Swedish Society of Medicine did me the honour of making me its member. This was the first recognition of this kind which came to me after the appearance of my work, and I would like to mention again today, here in the home of the Society, the great pleasure which I felt then and which I still recall with sincere gratitude. Before I go on to relate the principal results of my investigations on Spirop- tera carcinoma and the experimental induction of cancer, I would like to be allowed to offer the Nobel Foundation and the Staff of Professors of the Caroline Medio-Surgical Institute my most sincere and humble thanks for the great honour they have done me by finding my experiments worthy of the Nobel Prize in Physiology or Medicine. It is possible to trace back attempts at supplementing clinical and anatom- ical studies of cancer by means of experimental work on the disease’s origins, development and dissemination in the organism over a great number of years; not only the first, primitive experiments made over 150 years ago, but many more recent ones met with only negative results up to a short time ago.
    [Show full text]
  • Illustrations from the Wellcome Library AJE
    Medical History, 2002, 46: 569-579 Illustrations from the Wellcome Library A J E Terzi and L W Sambon: Early Italian Influences on Patrick Manson's "Tropical Medicine", Entomology, and the Art of Entomological Illustration in London LISE WILKINSON* On the death of Silas M Burroughs in February 1895, and after unpleasant legal arguments with Burroughs' estate, Henry Wellcome at last found himself in sole charge of Burroughs Wellcome & Co.; from then on he could, and did, shape its future to include his own interests not only in scientific research, but also in the history of medicine. In 1896 he engaged C J S Thompson to "research history of medicine and collect objects and books".' That marked the beginnings ofthe priceless collections now housed in the London Wellcome Library. Many of the objects there, books as well as works ofart, have been subjected to scrutiny by scholars and younger generations of students over the years; but parts of the iconographic collections are less well known, among them a series ofwatercolours, drawings, etc. ofentomological specimens and diseased patients, as well as caricatures of friends and colleagues, all showing the professional versatility and expertise of the artist, A J E Terzi. Terzi and other contemporaries might have deserved mention in the discussion which followed C P Snow's (1905-1980) Rede Lecture on 'The Two Cultures' in 1959.2 Snow's interest in his subject had grown from interdisciplinary discussions and table talk in Cambridge common rooms; stripped to their essentials, the underlying ideas called for closer political and educational understanding of, and co-operation between, "new" scientific knowledge and the humanities.
    [Show full text]
  • Questions of Quality: the Danish State Serum Institute, Thorvald Madsen and Biological Standardisation
    Questions of quality: The Danish State Serum Institute, Thorvald Madsen and Biological Standardisation Anne Hardy Published in Christoph Gradmann and Jonathan Simon eds, Evaluating and Standardizing Therapeutic Agents, 1890-1950 (Basingstoke: Palgrave MacMillan, 2010): 139-152. The opening of the Danish State Serum Institute in Copenhagen on 9 September 1902 was a festive occasion, attended by renowned figures from the wider bacteriological community including the German scientists Paul Ehrlich, Carl Weigert, and Julius Morgenroth, future Nobel prize-winner Svante Arrhenius from Sweden, Ole Malm and Armauer Hansen from Norway, and William Bulloch and German Sims Woodhead from England.1 Established as a national resource for the production of diphtheria antitoxin, the DSSI was from its inception concerned to deliver a quality product at a minimum price, and to link pharmaceutical production with research into, and further development of, biological products. In the course of the twentieth century, the institute acquired an international reputation for the quality of its products and its cutting edge research, and, in the 1920s, achieved international authority as the League of Nations Health Commission’s central laboratory for the preservation and distribution of all standard sera and bacterial products.2 The rise of the DSSI to international prominence came about through a combination of factors, personal, scientific and political , but above all, perhaps, from its early association with questions of quality in the production of the new generation biological medicines, of which diphtheria anti toxin was the first to emerge. Diphtheria and the Development of the Danish State Serum Institute The creation of the DSSI was largely due to the energy and determination of Carl Julius Salomonsen (1847-1924), the ‘father of danish bacteriology’,3 for Danish medical culture at that period was largely traditional with a focus on hospital medicine and general practice, rather than on research, let alone bacteriology.
    [Show full text]
  • Tion to True Malignant Tumors; with Some Remarks on Cancer Age
    ON SPIROPTERA CARCINOMATA AND THEIR RELA- TION TO TRUE MALIGNANT TUMORS; WITH SOME REMARKS ON CANCER AGE JOHANNES FIBIGER From the Anatomo-Pathological Institute of the University of Copenhagen Received for publication, July 25, 1919 In this Journal (1918, iii, 227) Bullock and Rohdenburg have criticized some reports published during the last years, concerning the experimental production of malignant tumors (Fibiger, Yamagiwa and Ichikawa) and tumor-like formations (Stahr). Bullock and Rohdenburg emphasize that An analysis of the several reports mentioned reveals a number of assertions common to each, which are at variance with the recognized laws of malignant tumor growth, while, at the same time, it brings out points which cast a certain amount of doubt upon the authors’ interpretation of their results. In the following I shall reply to Bullock and Rohdenburg’s criticism, though only in so far as it concerns the investigations on Spiroptera carcinoma communicated by me. I can so much the less avoid occupying myself with the assertions of these authors as their untenability seems to some extent to be due to an insufficient acquaintance with or a misapprehension of the details of my investigations of 1913 and 1914 (14). My most recently concluded investigations (&11), which corroborate the results of the former, were not published until after the appearance of the authors’ paper and so could not be known to them. Bullock and Rohdenburg base part of their criticism on a comparison between the result of my investigations on Spiroptera carcinoma and the result of investigations carried out by them- 367 368 JOHANNES FIBIGER selves on the effect of mechanical, chemical, or mechanico- chemical irritants’ on the stomach of the rat.
    [Show full text]
  • Science Vision 17, 33-52 (2017)
    Science Vision 17, 33-52 (2017) Available at SCIENCE VISION www.sciencevision.org SCIENCE VISION Historical Research OPEN ACCESS The making of oncology: The tales of false carcinogenic worms K. Lalchhandama Department of Zoology, Pachhunga University College, Aizawl 796001, Mizoram, India Cancer is a disease of antiquity. The Ancient Greeks were familiar with onkos (from Received 23 January 2017 Accepted 15 February 2017 which we have the term oncology)—tumour of all sorts. Hippocrates coined karki- nos and karkinoma, our source of the words cancer and carcinoma. Of a plethora *For correspondence : of carcinogens, parasitic worms (helminths) constitute a considerable health con- [email protected] cern. Three trematodes, Clonorchis sinensis, Opisthorchis viverrini, and Schisto- soma haematobium are now officially classified carcinogens. But the discovery of helminths as cancer-causing agents took wrong turns and marks an inglorious chapter in the history of science. The carcinogenicity of worms, vindicating Rudolf Virchow’s reiztheorie (irritation theory) of cancer origin, was glorified in the scien- tific forefront by Johannes Fibiger in the 1910s. Discovery of a new nematode, which he proudly named Spiroptera carcinoma, and his subsequent demonstration that the parasite could induce stomach cancer in rats, earned Fibiger a retrospec- tive Nobel Prize in Physiology or Medicine in 1926, and a lasting fame. But not in an appealing way. His achievement did not withstand the test of time. S. carci- noma was annulled as an invalid taxon in zoology—supplanted by Gongylonema neoplasticum—and eventually was branded as a non-carcinogenic agent. Contact us : [email protected] Key words: Gongylonema neoplasticum; helminth; Fibiger; cancer; Nobel Prize.
    [Show full text]
  • Why So Few Nobel Prizes for Cancer Researchers?
    The University of Manchester Research Why so few Nobel Prizes for cancer researchers? DOI: https://doi.org/10.1007/s00432-021-03671-x Document Version Final published version Link to publication record in Manchester Research Explorer Citation for published version (APA): Hansson, N., Padrini, G., Moll, F. H., Halling, T., & Timmermann, C. (2021). Why so few Nobel Prizes for cancer researchers? An analysis of Nobel Prize nominations for German physicians with a focus on Ernst von Leyden and Karl Heinrich Bauer. Journal of Cancer Research and Clinical Oncology. https://doi.org/10.1007/s00432-021- 03671-x Published in: Journal of Cancer Research and Clinical Oncology Citing this paper Please note that where the full-text provided on Manchester Research Explorer is the Author Accepted Manuscript or Proof version this may differ from the final Published version. If citing, it is advised that you check and use the publisher's definitive version. General rights Copyright and moral rights for the publications made accessible in the Research Explorer are retained by the authors and/or other copyright owners and it is a condition of accessing publications that users recognise and abide by the legal requirements associated with these rights. Takedown policy If you believe that this document breaches copyright please refer to the University of Manchester’s Takedown Procedures [http://man.ac.uk/04Y6Bo] or contact [email protected] providing relevant details, so we can investigate your claim. Download date:23. Sep. 2021 Journal of Cancer Research and Clinical Oncology https://doi.org/10.1007/s00432-021-03671-x ORIGINAL ARTICLE – CANCER RESEARCH Why so few Nobel Prizes for cancer researchers? An analysis of Nobel Prize nominations for German physicians with a focus on Ernst von Leyden and Karl Heinrich Bauer Nils Hansson1 · Giacomo Padrini1 · Friedrich H.
    [Show full text]